AVENUE THERAPEUTICS CEO Alexandra MacLean's 2023 pay jumps 304% to $1.2M

AVENUE THERAPEUTICS reports 2023 executive compensation

By ExecPay News

Published: May 3, 2024

AVENUE THERAPEUTICS reported fiscal year 2023 executive compensation information on May 3, 2024.
In 2023, two executives at AVENUE THERAPEUTICS received on average a compensation package of $737K, a 145% increase compared to previous year.
Average pay of disclosed executives at AVENUE THERAPEUTICS
Alexandra MacLean, Chief Executive Officer, received $1.2M in total, which increased by 304% compared to 2022. 66% of MacLean's compensation, or $800K, was in option awards. MacLean also received $400K in salary and $13K in other compensation.
David Jin, Chief Financial Officer, received a compensation package of $260K. 100% of the compensation package, or $260K, was in option awards.

Related executives

Alexandra MacLean

AVENUE THERAPEUTICS

Chief Executive Officer

David Jin

AVENUE THERAPEUTICS

Chief Financial Officer

You may also like

Source: SEC filing on May 3, 2024.